AGF MANAGEMENT LTD

Position in ABT — Abbott Laboratories

CIK 1003518 TORONTO, A6

Position in ABT

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$3,183,340

-$209,492 QoQ

Shares Held

35,082

+6.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#894

of 2,959 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AGF MANAGEMENT LTD holds $10,505,861 across 5 Medical Devices names. ABT ranks #2 (30.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	85,432	$3,646,237
2	ABT	Abbott Laboratories This page	35,082	$3,183,340
3	PEN	Penumbra Inc	9,492	$2,997,098
4	DXCM	Dexcom Inc	5,458	$367,596
5	MDT	Medtronic plc	3,983	$311,590

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,183,340	35,082	+6.2%	Shares	Sole	2026-08-10
2026-03-31	$3,392,832	33,046	+37.6%	Shares	Sole	2026-05-07
2025-12-31	$3,009,214	24,018	-7.3%	Shares	Sole	2026-02-17
2025-09-30	$3,471,322	25,917	+5.7%	Shares	Sole	2025-11-04
2025-06-30	$3,334,964	24,520	+13.2%	Shares	Sole	2025-08-06
2025-03-31	$2,874,524	21,670	+91.9%	Shares	Sole	2025-05-12
2024-12-31	$1,277,011	11,290	-17.3%	Shares	Sole	2025-02-07
2024-09-30	$1,556,919	13,656	+7.2%	Shares	Sole	2024-11-12
2024-06-30	$1,323,500	12,737	+365.5%	Shares	Sole	2024-08-07
2024-03-31	$310,973	2,736	+3.1%	Shares	Sole	2024-05-13
2023-12-31	$292,235	2,655	-20.2%	Shares	Sole	2024-02-06
2023-09-30	$322,123	3,326	-79.2%	Shares	Sole	2023-11-13
2023-03-31	$1,618,539	15,984	+15.4%	Shares	Sole	2023-05-02
2022-12-31	$1,520,591	13,850	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.